Wu, Y., Wang, F., Shen, C., Peng, W., Li, D., Zhao, C., ... & Liu, L. (2020). A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science, 368(6496), 1274-1278.

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

Yuan, M., Liu, H., Wu, N. C., Lee, C. C. D., Zhu, X., Zhao, F., ... & Wilson, I. A. (2020). Structural basis of a shared antibody response to SARS-CoV-2. Science, 369(6507), 1119-1123.

Structural basis of a shared antibody response
to SARS-CoV-2

- A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
- Structural basis of a shared antibody response
to SARS-CoV-2

State University of New York at Stony Brook

- Antibody Therapeutics
-  MedRxiv Preprint Papers
- Preprints
- Science

References for Antibodies and COVID-19 by journal

Preprints Papers of Articles Related to Antibodies and COVID-19

-  Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients
- SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months
-  Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–[negative] implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
- Comparative performance of five commercially available serologic assays to detect antibodies to SARS-coV-2 and identify individuals with high neutralizing titers. 

MedRxiv Preprint Papers Related to SARS-CoV-2 Antibody Testing

- Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective 

Learn Before

Related

Learn After